Use of Cyrene™, as an alternative to dimethyl sulfoxide, as a diluent for Melatonin to determine its in vitro antimicrobial capacity
Archives of Microbiology · 2024
DOI: 10.1007/s00203-024-04151-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, 2024. Verfasst von Ana Muñoz-Jurado und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Physiology and Immunology, Faculty of Veterinary Medicine, University of Cordoba, Campus of Rabanales, Cordoba, 14071, Sp…. Hauptthemen laut MEDLINE: Melatonin, Dimethyl Sulfoxide, Microbial Sensitivity Tests, Solvents. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Córdoba.
Abstract (Originalsprache)
Melatonin (MLT) is a methoxyindole that has potent antioxidant actions, anti-inflammatory, and antiapoptotic capacity. However, its in vitro antibacterial capacity has been the least studied of its properties. Dimethylsulfoxide (DMSO) has been the most used solvent for these tests, but it shows an antimicrobial effect if it is not dissolved. Cyrene™ is a new solvent that has emerged as an alternative to DMSO. Therefore, this study aimed to determine the antimicrobial capacity of MLT by MIC assays, using Cyrene™ as a solvent. Likewise, the solubility of MLT in this solvent and whether it exerted any effect on bacterial growth at different percentages was also determined. Different dilutions of MLT in Cyrene™ with different concentrations, were prepared. No growth inhibition caused by MLT was observed. The growth inhibition observed was because of Cyrene™. The maximum amount of MLT that can be diluted in 100% Cyrene is 10 mg/mL, but this percentage of solvent shows a bactericidal effect. Therefore, it must be dissolved at 5% to avoid this effect, so only 4 mg/mL of MLT can be diluted in it. Therefore, if no other solvents are available, the in vitro antibacterial role of MLT cannot be adequately assessed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Physiology and Immunology, Faculty of Veterinary Medicine, University of Cordoba, Campus of Rabanales, Cordoba, 14071, Spain. b22mujua@uco.es.
- Maimonides Institute for Research in Biomedicine of Cordoba, (IMIBIC), Cordoba, 14004, Spain. b22mujua@uco.es.
- CICAP-Food Research Centre, Pozoblanco, Cordoba, 14400, Spain.
- Maimonides Institute for Research in Biomedicine of Cordoba, (IMIBIC), Cordoba, 14004, Spain.
- Neurology Service, Reina Sofia University Hospital, Cordoba, 14004, Spain.
- Department of Biochemistry and Molecular Biology, Faculty of Medicine and Nursing, University of Cordoba, Cordoba, 14004, Spain.
Förderung
- Universidad de Córdoba
Zitieren
APA
Muñoz-Jurado, A., Jurado-Martos, F., Agüera, E., Túnez, I., & Escribano, B. M. (2024). Use of Cyrene™, as an alternative to dimethyl sulfoxide, as a diluent for Melatonin to determine its in vitro antimicrobial capacity. Archives of Microbiology. https://doi.org/10.1007/s00203-024-04151-9
Vancouver
Muñoz-Jurado A, Jurado-Martos F, Agüera E, Túnez I, Escribano BM. Use of Cyrene™, as an alternative to dimethyl sulfoxide, as a diluent for Melatonin to determine its in vitro antimicrobial capacity. Archives of Microbiology. 2024. doi:10.1007/s00203-024-04151-9
BibTeX
@article{MuozJurado2024,
author = {Muñoz-Jurado, Ana and Jurado-Martos, Francisco and Agüera, Eduardo and Túnez, Isaac and Escribano, Begoña M},
title = {Use of Cyrene™, as an alternative to dimethyl sulfoxide, as a diluent for Melatonin to determine its in vitro antimicrobial capacity},
journal = {Archives of Microbiology},
year = {2024},
doi = {10.1007/s00203-024-04151-9}
}
EUVIMED